JP2002523518A5 - - Google Patents

Download PDF

Info

Publication number
JP2002523518A5
JP2002523518A5 JP2000567569A JP2000567569A JP2002523518A5 JP 2002523518 A5 JP2002523518 A5 JP 2002523518A5 JP 2000567569 A JP2000567569 A JP 2000567569A JP 2000567569 A JP2000567569 A JP 2000567569A JP 2002523518 A5 JP2002523518 A5 JP 2002523518A5
Authority
JP
Japan
Prior art keywords
peptide
amino acid
acid
hydrophobic amino
peptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000567569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002523518A (ja
JP4528443B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/019378 external-priority patent/WO2000012553A1/en
Publication of JP2002523518A publication Critical patent/JP2002523518A/ja
Publication of JP2002523518A5 publication Critical patent/JP2002523518A5/ja
Application granted granted Critical
Publication of JP4528443B2 publication Critical patent/JP4528443B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000567569A 1998-08-28 1999-08-20 環状プロサポシン由来のペプチドおよびその使用 Expired - Fee Related JP4528443B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9835998P 1998-08-28 1998-08-28
US60/098,359 1998-08-28
PCT/US1999/019378 WO2000012553A1 (en) 1998-08-28 1999-08-20 Cyclic prosaposin-derived peptides and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010034833A Division JP2010150272A (ja) 1998-08-28 2010-02-19 環状プロサポシン由来のペプチドおよびその使用

Publications (3)

Publication Number Publication Date
JP2002523518A JP2002523518A (ja) 2002-07-30
JP2002523518A5 true JP2002523518A5 (cg-RX-API-DMAC10.html) 2006-08-10
JP4528443B2 JP4528443B2 (ja) 2010-08-18

Family

ID=22268937

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000567569A Expired - Fee Related JP4528443B2 (ja) 1998-08-28 1999-08-20 環状プロサポシン由来のペプチドおよびその使用
JP2010034833A Pending JP2010150272A (ja) 1998-08-28 2010-02-19 環状プロサポシン由来のペプチドおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010034833A Pending JP2010150272A (ja) 1998-08-28 2010-02-19 環状プロサポシン由来のペプチドおよびその使用

Country Status (13)

Country Link
EP (1) EP1105420A1 (cg-RX-API-DMAC10.html)
JP (2) JP4528443B2 (cg-RX-API-DMAC10.html)
KR (1) KR20010079695A (cg-RX-API-DMAC10.html)
CN (1) CN1324367A (cg-RX-API-DMAC10.html)
AU (1) AU751034B2 (cg-RX-API-DMAC10.html)
BR (1) BR9913490A (cg-RX-API-DMAC10.html)
CA (1) CA2341810A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ2001655A3 (cg-RX-API-DMAC10.html)
HU (1) HUP0103265A3 (cg-RX-API-DMAC10.html)
IL (1) IL141586A0 (cg-RX-API-DMAC10.html)
PL (1) PL204359B1 (cg-RX-API-DMAC10.html)
WO (1) WO2000012553A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200102489B (cg-RX-API-DMAC10.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
WO2000012553A1 (en) * 1998-08-28 2000-03-09 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof
AUPQ084899A0 (en) * 1999-06-08 1999-07-01 University Of Melbourne, The Neurotrophin agonists
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
CN100366286C (zh) * 2003-04-28 2008-02-06 常州南云科技有限公司 Saposin C-DOPS:一种抗癌新药
CN101583346B (zh) 2006-04-28 2015-08-19 儿童医院医疗中心 用于穿膜药物递送系统的皂化蛋白c和相关蛋白及肽的促融合性质
CA2666953A1 (en) * 2006-10-20 2008-05-02 Children's Hospital Medical Center Spontaneous forming ellipsoidal phospholipid unilamellar vesicles
CN103275187B (zh) * 2013-06-14 2014-10-29 四川合泰新光生物科技有限公司 一种镇痛肽fi及其基因和应用
US11291616B2 (en) 2015-04-23 2022-04-05 The Procter And Gamble Company Delivery of surfactant soluble anti-dandruff agent
BR112018067494B1 (pt) 2016-03-03 2022-05-10 The Procter & Gamble Company Composição anticaspa em aerossol
EP3528774A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam designating hair volume benefits
JP6952768B2 (ja) 2016-10-21 2021-10-20 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 低粘度であり粘度低減剤を含む、安定なコンパクトシャンプー製品
EP3528896A1 (en) 2016-10-21 2019-08-28 The Procter & Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
US11154467B2 (en) 2016-10-21 2021-10-26 The Procter And Gamble Plaza Concentrated shampoo dosage of foam designating hair conditioning benefits
EP3528897A1 (en) 2016-10-21 2019-08-28 The Procter & Gamble Company Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space
EP3528894A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
CN109862944A (zh) 2016-10-21 2019-06-07 宝洁公司 用于以最佳制剂空间递送消费者所需的剂型体积和表面活性剂量的泡沫剂型
US11141370B2 (en) 2017-06-06 2021-10-12 The Procter And Gamble Company Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
US11224567B2 (en) 2017-06-06 2022-01-18 The Procter And Gamble Company Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
EP4400092A3 (en) 2017-10-10 2024-10-16 The Procter & Gamble Company Compact shampoo composition with amino acid based anionic surfactants and cationic polymers
US10426713B2 (en) 2017-10-10 2019-10-01 The Procter And Gamble Company Method of treating hair or skin with a personal care composition in a foam form
JP6974928B2 (ja) 2017-10-10 2021-12-01 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company コンパクトなシャンプー組成物
WO2019074989A1 (en) 2017-10-10 2019-04-18 The Procter & Gamble Company COMPACT SHAMPOO COMPOSITION CONTAINING SULFATE-FREE SURFACTANTS
CN111556743B (zh) 2017-12-20 2023-07-18 宝洁公司 包含硅氧烷聚合物的澄清洗发剂组合物
EP3813774A1 (en) 2018-06-29 2021-05-05 The Procter & Gamble Company Low surfactant aerosol antidandruff composition
US12226505B2 (en) 2018-10-25 2025-02-18 The Procter & Gamble Company Compositions having enhanced deposition of surfactant-soluble anti-dandruff agents
WO2021113583A1 (en) 2019-12-06 2021-06-10 The Procter & Gamble Company Sulfate free composition with enhanced deposition of scalp active
WO2021173203A1 (en) 2020-02-27 2021-09-02 The Procter & Gamble Company Anti-dandruff compositions with sulfur having enhanced efficacy and aesthetics
WO2022109094A1 (en) 2020-11-23 2022-05-27 The Procter & Gamble Company Personal care compositions free of sulfated surfactants
JP7768985B2 (ja) 2020-12-04 2025-11-12 ザ プロクター アンド ギャンブル カンパニー 悪臭低減物質を含むヘアケア組成物
US12409125B2 (en) 2021-05-14 2025-09-09 The Procter & Gamble Company Shampoo compositions containing a sulfate-free surfactant system and sclerotium gum thickener
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants
CA3235522A1 (en) 2021-12-09 2023-06-15 The Procter & Gamble Company Sulfate free personal cleansing composition comprising effective preservation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106106A0 (en) * 1993-06-22 1993-10-20 Interpharm Lab Ltd Library of polymeric molecules and its preparation
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
WO2000012553A1 (en) * 1998-08-28 2000-03-09 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof

Similar Documents

Publication Publication Date Title
JP3266311B2 (ja) 新規ポリペプチドおよびこれを用いる抗hiv剤
CA1223198A (en) Repair of tissue in animals
US5482706A (en) Transmucosal therapeutic composition
JP4192114B2 (ja) 環式付着阻害剤
AU714846B2 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
CA2308116A1 (en) Low-toxicity human interferon-alpha analog
EP1077070A3 (en) Oral drug delivery compositions
US4603120A (en) Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use
JP2002524393A5 (cg-RX-API-DMAC10.html)
ATE172742T1 (de) Peptide mit wachstumshormonfreisetzender aktivität
DE69615838D1 (de) Cyclische wirkstoff-vorläufer verbindungen von peptiden und peptid-nukleicsäuren mit verbesserter metabolischer stabilität und zellmembran permeabilität
Fujino et al. Syntheses and biological activities of analogs of luteinizing hormone releasing hormone (LH-RH)
JP2004531242A5 (cg-RX-API-DMAC10.html)
CA2311648A1 (en) Ifnar2/ifn complex
RU2000109265A (ru) Лечение ожирения
US4684624A (en) Method of treating cerebral ischemia
HUT77979A (hu) Peptidek, előállításuk és ezeket tartalmazó gyógyszerkészítmények
JP2000502089A (ja) 成長ホルモンの放出を促進できるd―2―アルキルトリプトファンを含有するオリゴペプチド化合物
RU97107089A (ru) Полипептидные соединения, содержащие d-2-алкилтриптофан, стимулирующий высвобождение гормона роста
DE60133654D1 (de) Arzneimittel enthaltend analgetische peptide
RU2004104335A (ru) Биологически активные пептиды
US5807985A (en) Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
US4579841A (en) Dipeptide derivatives having opiate activity
CA2139571A1 (en) Interferon receptor binding peptides
GB2125408A (en) Luteinizing and follicle-stimulating hormones releasing factor analogs